Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05278780 · ClinicalTrials.gov registry record · NA
Medication Abortion With Autonomous Self-Assessment Project
A NA study, sponsored by Gynuity Health Projects.
- Completed
- Registry status
- NA
- Development phase
- 200
- Enrollment target
NCT05278780: Completed NA study, sponsored by Gynuity Health Projects.
NCT05278780 is a NA study that has completed, run by Gynuity Health Projects. The registered enrollment target is 200 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05278780, a NA study, has completed, sponsored by Gynuity Health Projects.
- COMPLETED
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
Study Summary
In this study, the investigators propose to create and pilot-test an asynchronous medication abortion provision service.
Primary Outcome
Proportion of treated participants with SAE (serious adverse effects) related to the study
Interventions
- OTHER Screening for eligibility
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2022-06-01 |
| Est. Completion | 2023-04-15 |
| Phase | NA |
What the finished NCT05278780 record still lists
NCT05278780 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower).
The record links to 0 conditions, and to 1 intervention - of which Screening for eligibility is the first listed.
NCT05278780 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05278780 about?
NCT05278780 is a clinical study titled "Medication Abortion With Autonomous Self-Assessment Project". In this study, the investigators propose to create and pilot-test an asynchronous medication abortion provision service.
What is the current status of trial NCT05278780?
This trial is currently completed. It is a NA study. The enrollment target is 200 participants. The study started on 2022-06-01. Estimated completion is 2023-04-15.
What interventions are being tested in trial NCT05278780?
The interventions under investigation include: Screening for eligibility (OTHER).
Who is sponsoring clinical trial NCT05278780?
This trial is sponsored by Gynuity Health Projects, which has 29 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05278780's enrollment target sits among peer trials
200 506th of 2000 higher than 1,434 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI